Background illustration for clinical trials search

Paid Clinical Trials Oakland

Discover 2,299 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes

for
Diabetes Mellitus, Type 2
Location: Oakland CA
Sponsor: Kaiser Permanente

Sex: All

Age: 21 - 44

Code: NCT05754008

Recruiting

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

for
Colonic Neoplasms
Location: Oakland CA, Orlando FL, Boston MA
Sponsor: AdventHealth Translational Research Institute

Sex: All

Age: 18+

Code: NCT05773144

Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Oakland CA, San Francisco CA, Palo Alto CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

Quality of End-of-Life Care for Children With Cancer

for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Oakland CA, Reno NV, Spokane WA, Dallas TX, Austin TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 18+

Code: NCT07412002

Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for
Astrocytoma, IDH-Mutant, Grade 3
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 12+

Code: NCT07215910

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18 - 39

Code: NCT03150693

Phase 3, Recruiting

Distance-Based Exercise to Preserve Function and Prevent Disability

for
Localized Malignant Solid Neoplasm, Anal Cancer,
Location: Oakland CA, San Francisco CA, Walnut Creek CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07059884

Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for
Clostridoides Difficile Associated Disease
Location: Oakland CA, Walnut Creek CA, Daly City CA,
Sponsor: Pfizer

Sex: All

Age: 65+

Code: NCT07282665

Phase 3, Recruiting

REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension

for
Hypertension, Aldosterone Disorder,
Location: Oakland CA
Sponsor: Kaiser Permanente

Sex: All

Age: 18+

Code: NCT07780500

Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase 3, Recruiting

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

for
Castration-Sensitive Prostate Carcinoma,
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT06931340

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Oakland CA, San Francisco CA, Walnut Creek CA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase 3, Recruiting

Safety of RSV Preventive Monoclonal Antibody

for
Fever, Adverse Event Following Immunisation
Location: Oakland CA, Cincinnati OH, Atlanta GA, Durham NC,
Sponsor: Duke University

Sex: All

Age: 0

Code: NCT07158814

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Oakland CA, Madera CA, Reno NV, Los Angeles CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Oakland CA, San Francisco CA, Palo Alto CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase 3, Recruiting

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Location: Oakland CA, Madera CA, Spokane WA, Albuquerque NM,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT07022678

Phase 3, Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase 3, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Oakland CA, San Francisco CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Oakland CA, San Francisco CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting